By the Numbers
In eight years, MaRS Innovation’s team has assessed 1,400 disclosures, created 60 companies and taken an additional 100 technologies under management.
Of our companies, 52 are growing in Canada. Collectively, they’ve attracted $160 million in external investment with $95 million coming from outside of Canada, and have created over 400 direct jobs.
Angel investors and venture firms investing in our portfolio hail from China, Germany, Hong Kong, the Kingdom of Saudi Arabia, the Netherlands, the United Kingdom and the United States.
Our industry partners include Baxter, GSK, Johnson & Johnson, LifeLabs, Merck, Pfizer and TandemLaunch.
Portfolio Companies and Technologies